Waldencast Acquisition (WALDU) Stock Price, News & Analysis

Company Overview

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

Key Stats

• Today's Range: $8.80 to $9.07
• 50-Day Range: $8.83 to $10.21
• 52-Week Range: $8.80 to $11.38
• Volume: 2,604 shs
• Average Volume: 83,629 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WALDU Stock Analysis - Frequently Asked Questions

When did Waldencast Acquisition IPO?

Waldencast Acquisition (WALDU) raised $250 million in an initial public offering (IPO) on Tuesday, March 16th 2021. The company issued 25,000,000 shares at $10.00 per share. Credit Suisse and J.P. Morgan acted as the underwriters for the IPO.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Shell Companies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:WALDU
• CIK: 1840199
• Web: www.waldencast.com
• Phone: 917 546 6828
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A